Saturday, 05/07/2008
Business Development
|
MedImmune’s Business Development team focuses on biologics business opportunities that support the company’s strategy across all therapy areas and works closely with other AstraZeneca Business Development groups. MedImmune is responsible for biologic product opportunities, and also for identifying Intellectual Property and technologies that enhance or extend the biologic technology platforms and products, including discovery and bioprocess development. We believe we need to be highly flexible in the type of relationships we form and look forward to building future partnerships to help deliver both our company’s and our partners’ strategies. Contact the Business Development team at: business.development@cambridgeantibody.com |
 |
Partners
To read more about our partnerships, and the evolution of CAT's collaborative business and earlier relationships, please click on the link below:
For a complete list of our partners and the relationships that we have with them, please click on the link below: